Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.340
-0.040 (-2.90%)
At close: Mar 18, 2026, 4:00 PM EDT
1.288
-0.052 (-3.88%)
After-hours: Mar 18, 2026, 4:52 PM EDT

Entera Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
8.578.6611.0212.3124.898.59
Cash & Short-Term Investments
8.578.6611.0212.3124.898.59
Cash Growth
23.99%-21.41%-10.48%-50.55%189.68%-43.41%
Accounts Receivable
-0.13-0.250.180.26
Other Current Assets
8.430.190.240.290.250.26
Total Current Assets
17.018.9711.2612.8525.339.11
Net Property, Plant & Equipment
0.310.330.490.230.40.57
Other Long-Term Assets
0.090.090.020.050.260.05
Total Assets
17.419.3911.7713.1325.999.72
Accounts Payable
0.220.130.080.020.170.16
Accrued Expenses
1.190.870.871.232.81.33
Current Portion of Leases
0.170.170.130.090.180.19
Unearned Revenue
----0.020.16
Total Current Liabilities
1.571.181.091.343.161.84
Long-Term Leases
0.040.10.26-0.120.24
Other Long-Term Liabilities
0.560.030.030.030.140.13
Total Long-Term Liabilities
0.60.130.290.030.260.37
Total Liabilities
2.171.311.381.373.422.21
Common Stock
0000-0
Additional Paid-in Capital
137.54121.97114.73107.21104.9577.71
Accumulated Other Comprehensive Income
0.040.040.040.040.040.04
Retained Earnings
-122.35-113.93-104.39-95.5-82.43-70.24
Shareholders' Equity
15.238.0810.3911.7522.577.51
Total Liabilities & Equity
17.419.3911.7713.1325.999.72
Total Debt
0.210.270.390.090.30.43
Net Cash (Debt)
8.368.3910.6312.2224.598.16
Net Cash Growth
-0.30%-21.08%-13.00%-50.31%201.31%-45.18%
Net Cash Per Share
0.190.220.370.420.940.44
Book Value
15.238.0810.3911.7522.577.51
Book Value Per Share
0.350.210.360.410.860.41
Tangible Book Value
15.238.0810.3911.7522.577.51
Tangible Book Value Per Share
0.350.210.360.410.860.41
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q